1. CACA guidelines for holistic integrative management of anticancer treatment - induced cutaneous adverse events.
- Author
-
Zhu, Guannan, Shi, Qiong, Cai, Tao, Gu, Dongcheng, Zhou, Hang, Wang, Lu, Liu, Fang, Wang, Ping, Xiong, Jianxia, Huang, Yujing, Li, Chunying, and Gao, Tianwen
- Subjects
TUMOR treatment ,SKIN disease treatment ,ANTIBIOTICS ,HEMORRHAGE risk factors ,BURNS & scalds -- Risk factors ,STEROID drugs ,LYMPHEDEMA treatment ,SCLERODERMA (Disease) treatment ,INFECTION risk factors ,HOLISTIC medicine ,MEDICAL protocols ,RISK assessment ,HAND-foot syndrome ,VASCULITIS ,ANTI-inflammatory agents ,CHINESE medicine ,WOUND healing ,SOFT tissue infections ,SKIN diseases ,STEVENS-Johnson Syndrome ,PSORIASIS ,ACNEIFORM eruptions ,SKIN tumors ,EXTRAVASATION ,SKIN inflammation ,ULCERS ,MICROSURGERY ,SARCOMA ,ABLATION techniques ,ERYTHEMA ,PHOTOSENSITIVITY disorders ,PROFESSIONAL associations ,MUCOUS membranes ,ENZYME inhibitors ,BALDNESS ,CHEMOEMBOLIZATION ,VITILIGO ,SEVERITY of illness index ,PHARMACEUTICAL gels ,PIGMENTATION disorders ,CHEMORADIOTHERAPY ,HEMATOMA ,SCARS ,FEVER ,CRYOSURGERY ,PHOTOTHERAPY ,ITCHING ,ANALGESICS ,LASER therapy ,MONOCLONAL antibodies ,IMMUNE checkpoint inhibitors ,OPERATIVE surgery ,METASTASIS ,INJECTIONS ,QUALITY of life ,GROWTH factors ,PAIN ,MEDICAL screening ,DRUG eruptions ,KERATOSIS ,RADIODERMATITIS ,IMATINIB ,PHOTODYNAMIC therapy ,GLUCOCORTICOIDS ,SECONDARY primary cancer ,PREVENTIVE health services ,DIET therapy ,CLASSIFICATION ,DISEASE risk factors ,DISEASE complications - Abstract
Purpose: The skin and mucous membrane of cancer patients can be directly or indirectly impaired during the treatment of cancers, bringing about not physical but also psychological damages to cancer patients. A practical guideline is of great significance to improve the quality of life for patients suffered from cutaneous adverse events. Methods: This guideline was generated based on up-to-date evidence and the consensus of experts specialized in dermatology. Results: The current guideline include the baseline screening of skin and mucosal membranes, the manifestations of injuries on skin, mucosa and appendages, along with the treatment of them. The causal anti-tumor management include chemotherapy, radiotherapy, immune therapy and surgery. Conclusion: This guideline can be helpful to reduce the risk of cutaneous adverse events during anti-cancer treatment and improve the quality of life of patients suffered from these adverse events. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF